Adverse drug and device reactions in the oral cavity: surveillance and reporting.

@article{Zavras2013AdverseDA,
  title={Adverse drug and device reactions in the oral cavity: surveillance and reporting.},
  author={Athanasios I. Zavras and Gregory E Rosenberg and Jared D Danielson and Vassiliki M Cartsos},
  journal={Journal of the American Dental Association},
  year={2013},
  volume={144 9},
  pages={1014-21}
}
BACKGROUND According to the U.S. Centers for Disease Control and Prevention, 48 percent of Americans (roughly 144 million people) used at least one prescribed medication in the preceding month; 11 percent used five or more. The authors describe the U.S. Food and Drug Administration's (FDA's) MedWatch program, the safety surveillance system for drugs and devices in the United States, and the dentist's role with regard to voluntary reporting of adverse effects (AEs). They also identify the most… CONTINUE READING